GLENMARK LIFE SCIENCES LIMITED Company Profile Details at KooCapital.Com – Stock Market News Portal.
Glenmark Life Sciences Limited engages in the development and manufacture of non-commoditized active pharmaceutical ingredients. Its products focuses on chronic therapeutic areas, including cardiovascular disease, central nervous system disease, pain management, and diabetes. The company was founded on June 23, 2011 and is headquartered in Mumbai, India.
glenmark life sciences limited company operating in Health Technology Sector and dealing in Pharmaceuticals: Major. glenmark life sciences limited is SEBI Listed Company (India) and having:-
ISIN (An International Securities Identification Number): INE03Q201024
Equity Stock (National Stock Exchange) Symbol: GLS
NSE Link IS: https://www.nseindia.com/get-quotes/equity?symbol=GLS
BSE Link IS: https://www.bseindia.com/stock-share-price/glenmark-life-sciences-ltd/GLS/543322/
Glenmark Life Sciences, a subsidiary of Glenmark Pharmaceuticals Ltd, is one of the leading developers and manufacturers of select high-value Active Pharmaceutical Ingredients. The company further operates in Contract Development and manufacturing operations to offer services to specialty Pharmaceutical companies.
A subsidiary of Glenmark Pharmaceuticals[1] Glenmark Life Sciences (GLS) is a subsidiary of Glenmark Pharmaceuticals Ltd which launched the API business by setting up a manufacturing facility in 2001 to cater to the growth in the API segment across the world and in 2019, the API manufacturing business of Glenmark was spun off into GLS, which will act as an independent company and focus on API business
Glenmark Life Sciences (GLS) develops and manufactures a range of high-quality, industry-leading Active Pharmaceutical Ingredients (APIs) for pharmaceutical companies worldwide. Leveraging our state-of-the-art laboratories and manufacturing locations, we supply over 130 molecules to more than 700 customers, which include the world’s top 20 generic companies. From product selection & development to commercialization, we judiciously blend science, technology and economics to stay ahead of the curve. Our culture of environmental stewardship, responsible business practices and operational excellence makes us one of the most reliable and preferred partner in the industry. Our track record of regulatory compliance, cost advantage, speed and superior quality ensures business continuity for our customers spread over 65 countries, being one of the fastest growing API companies in the industry. Our revenue, historically generated from US and Europe, is rapidly expanding to new Emerging Geographies like South East Asia, Russia, Middle East, Japan and Latin America.
Our people are our key differentiator. Our knowledgeable, responsible and inspired team, of over 1400 colleagues from 7 nationalities, constantly challenges themselves to forge out-of-the-box solutions. For GLS employees, business is about relationships, hence we work as partners, who intend to preempt, meet and even exceed customer expectations.
At GLS, we embrace an approach to business that lays equal amount of emphasis on generating value for the economy, environment and the society.
GLS (www.glenmarklifesciences.com) was incorporated as an independent subsidiary of Glenmark Pharmaceuticals on January 1, 2019, to provide a strategic focus to the API business and help it unleash its full potential. Glenmark Pharmaceuticals (www.glenmarkpharma.com) is a 40 year-old integrated, research-driven, global pharmaceutical organization committed to enriching lives.
Glenmark Life Sciences stand with [Passion. Innovation. Partnership]
Company Website: http://www.glenmarklifesciences.com/
Company Website2: http://www.glenmarklifesciences.com/
LinkedIn page URL: https://in.linkedin.com/company/glenmark-life-sciences
Wiki Profile URL:
Popular Search Keywords: glenmark life sciences limited , company management , company history , company profile , company information , business directory , Stock Market News , annual report , quarterly results , profit and loss , Koo Capital , KooCapital.Com , KooCapital News , Health Technology Sector Company , Pharmaceuticals: Major industry
#glenmark #life #sciences #limited #company #management #company #history #company #profile #company #information #business #directory #stock #market #news #annual #report #quarterly #results #profit #and #loss #koo #capital #koocapital #com #koocapital #news #health #technology #sector #company #pharmaceuticals #major #industry
